echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Vaccine targeting one protein is effective against multiple cancers in multiple animals

    Vaccine targeting one protein is effective against multiple cancers in multiple animals

    • Last Update: 2022-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A vaccine targeting a certain protein is effective in treating a variety of cancers in several animals, a team of researchers affiliated with institutions in the Netherlands and one in Switzerland repo.


    In 2006, the same research team discovered that a protein called vimentin is produced in cancer tumors and is only present in the blood that nourishes the tum.


    The researchers treated 35 dogs with their vacci.


    The researchers concluded that their tests provided further evidence that vimentin blocks the immune system and promotes the development of new blood vessels in tumo.


    Nature Communications (202


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.